(Q35593993)

9 August 2017

1 reference

title

Sexual dysfunction with psychotropic drugs (English)

1 reference

9 August 2017

1 reference

Michael Gitlin

1

1 reference

PubMed ID

14640925

9 August 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

Expert Opinion on Pharmacotherapy

9 August 2017

1 reference

9 August 2017

4

1 reference

9 August 2017

12

1 reference

9 August 2017

2259-2269

1 reference

The neurobiology of sexual function

9 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Effects of SSRIs on sexual function: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Sexual dysfunction in the United States: prevalence and predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Dopamine and sexual behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Pharmacological analysis of male rat sexual behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Evidence that serotonin affects female sexual functioning via peripheral mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Androgens, behaviour and nocturnal erection in hypogonadal men: the effects of varying the replacement dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Androgens and male sexual function: a review of human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Prolactin levels and adverse events in patients treated with risperidone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Sexual Disturbances in Temporal Lobe Epilepsy: A Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Sexual side effects associated with valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Amantadine in the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Sildenafil and erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

Sildenafil use in patients with olanzapine-induced erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.12.2259

10.1517/14656566.4.12.2259

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14640925